Tag: for

Spain widens age limit for AstraZeneca jabs

The use of the AstraZeneca vaccine to protect against COVID-19 in Spain will be widened to include people aged 66-69, the health ministry announced Thursday. Amid fears the jab may cause blood clots, the government had on Wednesday limited the vaccine to 60-65 year-olds. “The aim is to complete the inoculation of the people who

For veterans, a hidden side effect of COVID: Feelings of personal growth

The U.S. military veteran population is known to have abnormally high rates of suicide, so health officials have been concerned that the COVID-19 pandemic might elevate risk of psychiatric disorders, particularly among those suffering from post-traumatic stress and related disorders. A recent national study of more than 3,000 veterans participating in the National Health and

Italy reserves AstraZeneca vaccine for over 60s

Italy will reserve AstraZeneca’s vaccine for the over 60s following concerns of a link to blood clots in younger people, the government’s top adviser on the coronavirus crisis announced Wednesday. The decision has been taken to “recommend the preferential use on individuals aged above 60”, Franco Locatelli told reporters. His announcement came hours after the

Valneva’s COVID-19 Shot Set for Phase Three Trial This Month

PARIS (Reuters) – Valneva on Tuesday reported positive results for its COVID-19 vaccine in early stage clinical trials and said it planned to launch a Phase Three trial this month. The French drugmaker, whose shot uses the technology behind its licensed Japanese encephalitis vaccine, tested its vaccine in 153 adults with three dose levels based

Designing better contact-tracing apps for the next pandemic

As COVID-19 began to spread last spring, apps were developed to track cellphone signals and other data so people who had been near those who were infected could be notified and asked to quarantine. The novel coronavirus rapidly outpaced such efforts, becoming so widespread that tracing individual exposures could not contain it. But the issues

Cell stress mechanisms identified as prognostic factor for chronic inflammatory liver disease

Primary sclerosing cholangitis (PSC) is a rare chronic inflammatory disease of the bile ducts and is difficult to treat, since its causes have not yet been adequately researched. Using RNA sequencing, an international research consortium led by Michael Trauner, Head of MedUni Vienna’s Division of Gastroenterology and Hepatology (Department of Medicine III), has now identified

Researchers describe how embryonic stem cells keep optimal conditions for use in regenerative medicine

Scientists at the Proteomics Core Unit of the Spanish National Cancer Research Centre (CNIO), headed by Javier Muñoz, have described the mechanisms, unknown to date, involved in maintaining embryonic stem cells in the best possible state for their use in regenerative medicine. Their results, published in Nature Communications, will help to find novel stem-cell therapies

Study find progesterone therapy may improve COVID-19 outcomes for men

COVID-19 disproportionately affects men compared with women, raising the possibility that a hormone like progesterone may improve clinical outcomes for certain hospitalized men with the disease. New research from Cedars-Sinai published online in the journal Chest supports this hypothesis. The pilot clinical trial, involving 40 men, is believed to be the first published study to

S.Africa trial shows promise for drug-resistant TB regimen

Almost all patients who received a new treatment for highly drug-resistant tuberculosis are still clear of the disease two years after a medical trial in South Africa, findings from a long-term study showed Thursday. By comparison, “five years ago if you were diagnosed with a drug resistant TB, at five years after diagnosis, eighty percent

Updated guidance confirms crucial role of nurses for patients with acute ischemic stroke

As integral members of stroke treatment teams, nurses coordinate patient assessment and collaborate care among multiple health care professionals to facilitate the best possible outcomes for patients with acute ischemic stroke. Nurses also advocate for patients and their caregivers to ensure they receive appropriate information and education to successfully navigate phases of treatment in the

AstraZeneca vaccine not to blame for Austria death: EMA

Europe’s medicines watchdog said Wednesday a preliminary probe showed that a batch of AstraZeneca vaccines used in Austria was likely not to blame for the death of a nurse who received a jab. Austria on Monday announced it would stop using doses from the batch, made by the British-Swedish firm with Oxford University, after the